Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Aeterna Zentaris licenses anticancer agent to Hikma

Nov. 24, 2011

UCB decides on option agreement to license SYN-118

Nov. 24, 2011

Companies collaborate on DNA-based therapy for pulmonary arterial hypertension

Nov. 22, 2011

Ajinomoto and Interprotein to collaborate on protein-protein interaction inhibitors

Nov. 21, 2011

Shionogi and Shire enter collaboration for two therapeutic agents for ADHD

Nov. 21, 2011

Alnylam Pharmaceuticals licenses InterfeRx to Sylentis

Nov. 21, 2011

Eisai and Novartis Pharma enter agreement on COPD therapies in Japan

Nov. 21, 2011

Roche and Aileron Therapeutics expand stapled peptide drug partnership

Nov. 18, 2011

Athersys regains rights to MultiStem cardiovascular program

Nov. 17, 2011

Genzyme and Cystic Fibrosis Foundation enter collaboration for new cystic fibrosis drugs

Nov. 17, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...